Giuseppe Orlando to Recurrence
This is a "connection" page, showing publications Giuseppe Orlando has written about Recurrence.
Connection Strength
0.317
-
Orlando G, Adam R, Mirza D, Soderdahl G, Porte RJ, Paul A, Burroughs AK, Seiler CA, Colledan M, Graziadei I, Garcia Valdecasas JC, Pruvot FR, Karam V, Lerut J. Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience. Transplantation. 2013 Mar 27; 95(6):872-7.
Score: 0.103
-
Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Transpl Immunol. 2008 Nov; 20(1-2):43-7.
Score: 0.075
-
Orlando G, Blairvacq JS, Otte JB, Goffette P, Ciccarelli O, Sempoux C, Lerut J. Successful treatment of recurrent cholangitis after adult liver transplantation with a Tsuchida antireflux valve. Transplantation. 2004 Apr 27; 77(8):1307-8.
Score: 0.055
-
Lerut JP, Pinheiro RS, Lai Q, Stouffs V, Orlando G, Juri JM, Ciccarelli O, Sempoux C, Roggen FM, De Reyck C, Latinne D, Gianello P. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. Ann Surg. 2014 Nov; 260(5):886-91; discussion 891-2.
Score: 0.029
-
Manzia TM, Angelico R, Toti L, Bellini MI, Sforza D, Palmieri G, Orlando G, Tariciotti L, Angelico M, Tisone G. Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C. Transpl Int. 2011 May; 24(5):461-8.
Score: 0.022
-
Lerut J, Orlando G, Adam R, Sabbà C, Pfitzmann R, Klempnauer J, Belghiti J, Pirenne J, Thevenot T, Hillert C, Brown CM, Gonze D, Karam V, Boillot O. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg. 2006 Dec; 244(6):854-62; discussion 862-4.
Score: 0.017
-
Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, Baiocchi L, Lionetti R, Anselmo A, Toti L, Angelico M. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006 Apr; 44(4):702-9.
Score: 0.016